Literature DB >> 33481935

Reliable, scalable functional genetics in bloodstream-form Trypanosoma congolense in vitro and in vivo.

Georgina Awuah-Mensah1, Jennifer McDonald1, Pieter C Steketee2, Delphine Autheman3, Sarah Whipple1, Simon D'Archivio1, Cordelia Brandt4, Simon Clare4, Katherine Harcourt4, Gavin J Wright3,5, Liam J Morrison2, Catarina Gadelha1, Bill Wickstead1.   

Abstract

Animal African trypanosomiasis (AAT) is a severe, wasting disease of domestic livestock and diverse wildlife species. The disease in cattle kills millions of animals each year and inflicts a major economic cost on agriculture in sub-Saharan Africa. Cattle AAT is caused predominantly by the protozoan parasites Trypanosoma congolense and T. vivax, but laboratory research on the pathogenic stages of these organisms is severely inhibited by difficulties in making even minor genetic modifications. As a result, many of the important basic questions about the biology of these parasites cannot be addressed. Here we demonstrate that an in vitro culture of the T. congolense genomic reference strain can be modified directly in the bloodstream form reliably and at high efficiency. We describe a parental single marker line that expresses T. congolense-optimized T7 RNA polymerase and Tet repressor and show that minichromosome loci can be used as sites for stable, regulatable transgene expression with low background in non-induced cells. Using these tools, we describe organism-specific constructs for inducible RNA-interference (RNAi) and demonstrate knockdown of multiple essential and non-essential genes. We also show that a minichromosomal site can be exploited to create a stable bloodstream-form line that robustly provides >40,000 independent stable clones per transfection-enabling the production of high-complexity libraries of genome-scale. Finally, we show that modified forms of T. congolense are still infectious, create stable high-bioluminescence lines that can be used in models of AAT, and follow the course of infections in mice by in vivo imaging. These experiments establish a base set of tools to change T. congolense from a technically challenging organism to a routine model for functional genetics and allow us to begin to address some of the fundamental questions about the biology of this important parasite.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33481935      PMCID: PMC7870057          DOI: 10.1371/journal.ppat.1009224

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  58 in total

1.  Tetracycline-regulated RNA interference in Trypanosoma congolense.

Authors:  Noboru Inoue; Keiko Otsu; Debra M Ferraro; John E Donelson
Journal:  Mol Biochem Parasitol       Date:  2002-04-09       Impact factor: 1.759

2.  Targeting of a tetracycline-inducible expression system to the transcriptionally silent minichromosomes of Trypanosoma brucei.

Authors:  Bill Wickstead; Klaus Ersfeld; Keith Gull
Journal:  Mol Biochem Parasitol       Date:  2002 Nov-Dec       Impact factor: 1.759

3.  High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome.

Authors:  Sam Alsford; Daniel J Turner; Samson O Obado; Alejandro Sanchez-Flores; Lucy Glover; Matthew Berriman; Christiane Hertz-Fowler; David Horn
Journal:  Genome Res       Date:  2011-03-01       Impact factor: 9.043

4.  Cattle breeding, trypanosomosis prevalence and drug resistance in Northern Togo.

Authors:  E Tchamdja; A E Kulo; H S Vitouley; K Batawui; A A Bankolé; K Adomefa; G Cecchi; A Hoppenheit; P H Clausen; R De Deken; J Van Den Abbeele; T Marcotty; V Delespaux
Journal:  Vet Parasitol       Date:  2017-02-14       Impact factor: 2.738

5.  Genetic engineering of Trypanosoma (Dutonella) vivax and in vitro differentiation under axenic conditions.

Authors:  Simon D'Archivio; Mathieu Medina; Alain Cosson; Nathalie Chamond; Brice Rotureau; Paola Minoprio; Sophie Goyard
Journal:  PLoS Negl Trop Dis       Date:  2011-12-27

6.  A modular and optimized single marker system for generating Trypanosoma brucei cell lines expressing T7 RNA polymerase and the tetracycline repressor.

Authors:  S K Poon; L Peacock; W Gibson; K Gull; S Kelly
Journal:  Open Biol       Date:  2012-02       Impact factor: 6.411

7.  Site-specific DNA double-strand breaks greatly increase stable transformation efficiency in Trypanosoma brucei.

Authors:  Lucy Glover; David Horn
Journal:  Mol Biochem Parasitol       Date:  2009-08       Impact factor: 1.759

8.  Genome-scale RNAi screens for high-throughput phenotyping in bloodstream-form African trypanosomes.

Authors:  Lucy Glover; Sam Alsford; Nicola Baker; Daniel J Turner; Alejandro Sanchez-Flores; Sebastian Hutchinson; Christiane Hertz-Fowler; Matthew Berriman; David Horn
Journal:  Nat Protoc       Date:  2014-12-11       Impact factor: 13.491

9.  Non-invasive in vivo study of the Trypanosoma vivax infectious process consolidates the brain commitment in late infections.

Authors:  Simon D'Archivio; Alain Cosson; Mathieu Medina; Thierry Lang; Paola Minoprio; Sophie Goyard
Journal:  PLoS Negl Trop Dis       Date:  2013-01-03

10.  The Structure of a Conserved Telomeric Region Associated with Variant Antigen Loci in the Blood Parasite Trypanosoma congolense.

Authors:  Ali Hadi Abbas; Sara Silva Pereira; Simon D'Archivio; Bill Wickstead; Liam J Morrison; Neil Hall; Christiane Hertz-Fowler; Alistair C Darby; Andrew P Jackson
Journal:  Genome Biol Evol       Date:  2018-09-01       Impact factor: 3.416

View more
  2 in total

1.  Differences in Transporters Rather than Drug Targets Are the Principal Determinants of the Different Innate Sensitivities of Trypanosoma congolense and Trypanozoon Subgenus Trypanosomes to Diamidines and Melaminophenyl Arsenicals.

Authors:  Marzuq A Ungogo; Gustavo D Campagnaro; Ali H Alghamdi; Manal J Natto; Harry P de Koning
Journal:  Int J Mol Sci       Date:  2022-03-05       Impact factor: 5.923

2.  Divergent metabolism between Trypanosoma congolense and Trypanosoma brucei results in differential sensitivity to metabolic inhibition.

Authors:  Pieter C Steketee; Emily A Dickie; James Iremonger; Kathryn Crouch; Edith Paxton; Siddharth Jayaraman; Omar A Alfituri; Georgina Awuah-Mensah; Ryan Ritchie; Achim Schnaufer; Tim Rowan; Harry P de Koning; Catarina Gadelha; Bill Wickstead; Michael P Barrett; Liam J Morrison
Journal:  PLoS Pathog       Date:  2021-07-26       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.